trending Market Intelligence /marketintelligence/en/news-insights/trending/tinaDHhAe-MOAsuutoSIEg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sartorius Stedim Biotech to buy 3 Danaher life science businesses for $750M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sartorius Stedim Biotech to buy 3 Danaher life science businesses for $750M

Sartorius Stedim Biotech SA agreed to acquire three businesses from Danaher Corp.'s life science portfolio for about $750 million in cash.

The acquisition, which is part of a bigger transaction between Danaher and Sartorius Stedim parent Sartorius AG, will support the latter's positions in the bioanalytics and bioprocessing segments.

The businesses being acquired include Danaher's biomolecular characterization business, called FortéBio, its chromatography hardware and resins business and its microcarrier technology business, called SoloHill. The businesses had a combined sales turnover of about $140 million in 2018.

FortéBio, which develops protein analysis instruments, biosensors and reagents used in drug discovery will be integrated in Sartorius' bioanalytics unit, while the chromatography hardware and resins business will become part of Sartorius' bioprocess solutions division.

The proposed deal is expected to be completed in the first quarter of 2020, subject to certain conditions such as regulatory approvals. The transaction is also contingent on Danaher's acquisition of GE's biopharma business.

Sartorius AG is a Goettingen, Germany-based company developing pharmaceutical and laboratory equipment. Its unit Sartorius Stedim Biotech is a France-based seller of instruments and consumables for the biopharmaceutical industry.